Depleting GFPT2 in NSCLC resulted in attenuated cell migration and invasion, indicating the potential importance of modulating GFPT2 activity as a therapeutic target for combating NSCLC progression. This evidence concerns the gene GFPT2 and non-small cell lung carcinoma.